SPHINGOMYELIN AND OTHER PHOSPHOLIPID METABOLISM IN THE RABBIT ATHEROMATOUS AND NORMAL AORTA = METABOLISME DE LA SPHINGOMYELINE ET D'AUTRES PHOSPHOLIPIDES DANS L'AORTE ATHEROMATEUSE ET NORMALE DU LAPINSETH SK; NEWMAN HAI.1975; CIRCUL. RES.; U.S.A.; DA. 1975; VOL. 36; NO 2; PP. 294-299; BIBL. 24REF.Article

CLOFIBRATE AND RELATED ANALOGS.WITIAK DT; NEWMAN HAI; FELLER DR et al.1977; MEDICIN. RES. SER.; U.S.A.; DA. 1977; VOL. 7; PP. (296P.); BIBL. 91 P. 1/2; ISBN 0824766814Serial Issue

A DUAL QUALITY CONTROL SYSTEM FOR LARGE CLINICAL LABORATORIES = UN SYSTEME DE DOUBLE CONTROLE DE LA QUALITE POUR LES GRANDS LABORATOIRES CLINIQUESHEGGEN DW; NEWMAN HAI; KELLER MD et al.1972; AMER. J. CLIN. PATHOL.; U.S.A.; DA. 1972; VOL. 58; NO 1; PP. 37-42; BIBL. 4REF.Serial Issue

SYNTHESIS OF ETHYL-6-SUBSTITUTED-CHROMAN- AND -CHROMONE-2 CARBOXYLATES. A COMPARATIVE STRUCTURE-ACTIVITY STUDY EMPLOYING THE 6-PHENYL- AND PHENOXY ANALOGS IN THE TRITON HYPERLIPIDEMIC RAT MODELWITIAK DT; HEILMAN WP; SPANKARAPPA SK et al.1975; J. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 18; NO 9; PP. 934-942; BIBL. 40 REF.Article

POTENTIATING EFFECTS OF CLOFIBRATE ON PROSTAGLANDIN-DEPENDENT AND -INDEPENDENT PATHWAYS OF HUMAN PLATELET ACTIVATION: EVIDENCE FOR INVOLVEMENT OF CYCLIC AMPHUZOOR AKBAR; WITIAK DT; NEWMAN HAI et al.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 11; PP. 2125-2128; BIBL. 17 REF.Article

HISTOCHEMICAL ESTROGEN: RECEPTOR ASSAYRUSSELL J; NEWMAN HAI; SHARMA HM et al.1981; AM. J. CLIN. PATHOL.; ISSN 0002-9173; USA; DA. 1981; VOL. 75; NO 1; PP. 127-129; BIBL. 11 REF.Article

THE EFFECTS OF ASBESTOS ON PLASMA MEMBRANE; SURFACE GLYCOLIPIDS AND GLYCOPROTEINS OF SYRIAN HAMSTER EMBRYO CELLSSAAT YA; NEWMAN HAI; HART RW et al.1980; J. ENVIRON. PATHOL. TOXICOL.; USA; DA. 1980; VOL. 4; NO 1; PP. 435-441; BIBL. 16 REF.Article

PROPERTIES OF MYCOBACTERIOPHAGE DS6AII. LIPID COMPOSITIONBOWMAN BU; NEWMAN HAI; MORITZ JM et al.1973; AMER. REV. RESP. DIS.,; U.S.A.; DA. 1973; VOL. 107; NO 1; PP. 42-49; ABS. ESP. FR.; BIBL. 19REF.Serial Issue

INACTIVATION OF PHAGES DS6A AND D29 BY ACETONE EXTRACTS OF MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM BOVIS.BOWMAN BU JR; FISHER LJ; WITIAK DT et al.1975; AMER. REV. RESP. DIS.; U.S.A; DA. 1975; VOL. 112; NO 1; PP. 17-22; BIBL. 13 REF.Article

9-CHLORO-2,3-DIHYDRO-5H-1,4-DIOXEPINO (6,5-B) BENZOFURAN, A NOVEL ANTILIPIDEMIC AGENT STRUCTURALLY RELATED TO CLOFIBRATEWITIAK DT; POOCHIKIAN GK; FELLER DR et al.1975; J. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 18; NO 10; PP. 992-996; BIBL. 25 REF.Article

SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF CIS-3,4, -4A, 9A-TETRAHYDRO-14-PYRANO (3,4-B) BENZOFURAN-1-ONES. TRICYCLIC ANALOGUES RELATED TO THE ANTILEPIDEMIC DRUG CLOFIBRATEWITIAK DT; LOH W; FELLER DR et al.1979; J. MEDICIN. CHEM.; USA; DA. 1979; VOL. 22; NO 6; PP. 699-705; BIBL. 43 REF.Article

SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF A CLOFIBRATE-RELATED TRICYCLIC SPIROLACTONE, 5-CHLORO-4',5'-DIHYDROSPIRO (BENZOFURAN-2(3H), 3' (2'H)-FURAN)-2'-ONEWITIAK DT; CAVESTRI RC; NEWMAN HAI et al.1978; J. MEDICIN. CHEM.; USA; DA. 1978; VOL. 21; NO 12; PP. 1198-1202; BIBL. 37 REF.Article

EFFECTS OF CLOFIBRATE AND 6-SUBSTITUTED CHROMAN ANALOGS OF HUMAN PLATELET FUNCTION. I: MECHANISM OF INHIBITORY ACTIONHUZOOR AKBAR; PATEL S; KOKRADY SS et al.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 14; PP. 2013-2020; BIBL. 32 REF.Article

EFFECT OF VALIUM (DIAZEPAM) ON EXPERIMENTAL ATHEROSCLEROSIS IN ROOSTERSPATEL DJ; WONG HYC; NEWMAN HAI et al.1982; ARTERY; ISSN 0098-6127; USA; DA. 1982; VOL. 10; NO 4; PP. 237-249; BIBL. 15 REF.Article